Ozempic MDL 3094 CMOs

Below are links to the case management orders (CMOs) entered in the Ozempic lawsuit MDL 3094. Ozempic lawsuits have been filed around the nation alleging that the drug caused bowel obstructions and other GI disorders. Case management orders are an excellent way to stay up to date on the status of the Ozempic lawsuits that are part of MDL 3094. Bookmark this page so that you can check in on the latest Ozempic lawsuit updates.

• 05/01/2026: Anti-Discrimination and Harassment Notice – Eastern District of Pennsylvania (EDPA) [PDF]
• 04/30/2026: Amended Order Regarding Status Conferences [PDF]
• 04/30/2026: CMO 32 – Fifth Amended Scheduling Order for Cross-Cutting Issues [PDF]
• 01/14/2026: CMO 30 – Establishment of Streamlined Docket [PDF]
• 10/03/2025: CMO 27 – Short Form Complaint Enabling Order [PDF]
• 04/16/2025: CMO 26 – Plaintiffs’ Production of Electronically Stored Information (ESI)
• 03/21/2025: CMO 25 – Coordination Order for Related Actions
• 03/21/2025: CMO 24 – Deposition Protocol for Non-Experts
• 03/21/2025: CMO 23 – Amended Scheduling Order for Cross Cutting Issues 2 and 3
• 12/03/2024: CMO 22 – Scheduling Order for Motion to Dismiss the Master Complaint
• 11/26/2024: Status Conference Scheduling Order
• 11/25/2024: CMO 21 – Amended Scheduling Order for Cross Cutting Issue No. 1
• 08/23/2024: CMO 18 – Cross Cutting Issues
• 08/08/24: CMO 17 – Time and Expense Protocol & Common Benefit Funds
• 07/31/2024: CMO 16 – Special Master Appointment and Discovery Protocol
• 07/31/2024: CMO 15 – ****ESI Protocol
• 07/14/2024: CMO 14 – Direct Filing Order
• 07/24/2024: CMO 13 – Dismissal of Claims Against Certain Novo Defendants
• 07/12/2024: CMO 12 – Plaintiff Fact Sheets Protocol
• 07/12/2024: CMO 11 – Qualified Protective Order & Sealing Process
• 07/12/2024: CMO 10 – Rule 502(d) Order
• 06/25/2024: CMO 9 – Privilege Logging Order
• 06/10/2024: CMO 8 – Pro Hac Vice
• 06/06/2024: CMO 7 – Status Conference on June 10, 2024, with Honorable Karen Marston
• 05/08/2024: CMO 6 – Ozempic Leadership Expanded
• 04/26/2024: CMO 5 – Ozempic Science Day (Vacated)
• 04/23/2024: CMO 4 – Preservation Order
• 04/23/2024: CMO 3 – Initial Ozempic Leadership Appointments
• 02/16/2024: CMO 2 – Pro Hac Vice Appearances in Ozempic Lawsuits
• 02/15/2024: CMO 1 – Initial Ozempic Lawsuit Organizational Conference for Counsel with the Court and Related Preliminary Matters
• 02/02/2024: JPML Transfer Order – Creation of MDL 3094
• 11/18/2019: Employment Dispute Resolution (EDR) Plan – Eastern District of Pennsylvania [PDF]

Ozempic Lawsuit Information

For more information on each Ozempic case management order and the status of the Ozempic lawsuits in MDL 3094, visit our page on Ozempic Lawsuit MDL 3094. For a free Ozempic lawsuit consultation with one of our Ozempic attorneys, please call 202-792-7927.